Technical Breakout Stocks: How to trade Ajanta Pharma, BHEL and Hindustan Zinc on Monday?

Indian market witnessed profit-taking on Friday tracking muted global cues. The S&P BSE Sensex plunged more than 700 points while the Nifty50 closed below 22,500 levels.

Indian market witnessed profit-taking on Friday tracking muted global cues. The S&P BSE Sensex plunged more than 700 points while the Nifty50 closed below 22,500 levels.

Sectorally, buying was seen in metals, healthcare, and public sector while selling was seen in realty, capital goods and telecom indices which were down more than 1% each.

Stocks that were in focus include names like which was up more than 6%, closed with gains of more than 4% and closed with gains of more than 9% on Friday.

Analyst: Mitesh Karwa, Research Analyst at Bonanza Portfolio


Ajanta Pharma: Buy| Target Rs 2700| Stop Loss Rs 2250

Ajanta Pharma is seen to be opening with a big gap-up and breaking a resistance zone on the daily timeframe with above-average volumes and making a new all-time high on the daily timeframe which confirms the bullish view.

Buying can be initiated in Ajanta Pharma stock at current levels of around 2380-2383 with stoploss of 2250 and targets of 2700.
Ajanta PharmaETMarkets.com


BHEL: Book partial profits

BHEL LTD is seen to be achieving its technical target on the monthly timeframe and RSI is seen to be in an overbought zone which is why buying is not recommended at current levels.

Partial profit booking of current holding can be done at current levels as the stock might correct in the short term, although the longer-term trend is still sideways to bullish.
BHEL 3 MayETMarkets.com


Hindustan Zinc: Buy| Target Rs 540| Stop Loss Rs 370

Hindustan Zinc is seen to be breaking out of a bullish cup and handle-like formation on the monthly timeframe with a bullish candlestick and above-average volumes.

Buying can be done on dips of 420-430 with a stop loss below 370 and targets of 540.
Hindustan ZincETMarkets.com

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?